SXC vs DRUG

Comparison between SunCoke Energy Inc (SXC, Company) and Bright Minds Biosciences Inc (DRUG, Company).

SXC is from the Basic Materials sector, while DRUG is from the Healthcare sector.

5-Year PerformanceDRUG has outperformed SXC, delivering a return of +28.2% compared to +10.5%

SXC vs DRUG - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	SXC(COMPANY)	DRUG(COMPANY)
Market Cap	$732M	$728M
Max Drawdown	90.99%	97.68%
Sharpe Ratio	0.24	1.76
5Y Beta	0.76	-0.81
Industry	Coking Coal	Biotechnology
P/E Ratio	19.77	-30.85
Forward P/E	12.25	N/A
PEG Ratio	1.98	-0.08
Dividend Yield	5.68%	N/A
5Y Dividends CAGR	20.11%	N/A
5Y EPS CAGR	0.18%	8.42%
Debt to Equity	113.44%	0.03%
Free Cash Flow Yield	10.53%	-2.00%
P/S Ratio	0.39	N/A
P/B Ratio	1.23	3.34

Market Cap

Winner

SXC

$732M

DRUG

$728M

Max Drawdown

Winner

SXC

90.99%

DRUG

97.68%

Sharpe Ratio

SXC

0.24

Winner

DRUG

1.76

5Y Beta

SXC

0.76

Winner

DRUG

-0.81

Industry

SXC

Coking Coal

DRUG

Biotechnology

P/E Ratio

SXC

19.77

Winner

DRUG

-30.85

Forward P/E

SXC

12.25

DRUG

N/A

PEG Ratio

SXC

1.98

Winner

DRUG

-0.08

Dividend Yield

SXC

5.68%

DRUG

N/A

5Y Dividends CAGR

SXC

20.11%

DRUG

N/A

5Y EPS CAGR

SXC

0.18%

Winner

DRUG

8.42%

Debt to Equity

SXC

113.44%

Winner

DRUG

0.03%

Free Cash Flow Yield

Winner

SXC

10.53%

DRUG

-2.00%

P/S Ratio

SXC

0.39

DRUG

N/A

P/B Ratio

Winner

SXC

1.23

DRUG

3.34

SXC vs DRUG - Historical Returns

Returns include dividend reinvestment.

Period	SXC	DRUG
1 month	-3.24%	+23.00%
3 months	+32.68%	-17.82%
6 months	+10.62%	-10.11%
1 year	+5.20%	+185.42%
5 years(CAGR)	+10.51%	+28.20%
10 years(CAGR)	+5.13%	N/A
Max(CAGR)	-2.17%	+21.02%

SXC

-3.24%

Winner

DRUG

+23.00%

Winner

SXC

+32.68%

DRUG

-17.82%

Winner

SXC

+10.62%

DRUG

-10.11%

SXC

+5.20%

Winner

DRUG

+185.42%

5Y(CAGR)

SXC

+10.51%

Winner

DRUG

+28.20%

10Y(CAGR)

SXC

+5.13%

DRUG

N/A

Max(CAGR)

SXC

-2.17%

Winner

DRUG

+21.02%

SXC vs DRUG - Annual Returns (2011 - 2026)

Returns include dividend reinvestment.

Year	SXC	DRUG
2026	+17.87%	-10.60%
2025	-27.65%	+89.83%
2024	+3.70%	+1859.10%
2023	+32.44%	-63.33%
2022	+31.26%	-78.04%
2021	+47.22%	-41.30%
2020	-25.25%	N/A
2019	-28.08%	N/A
2018	-29.57%	N/A
2017	+6.11%	N/A
2016	+199.21%	N/A
2015	-80.95%	N/A
2014	-14.85%	N/A
2013	+41.33%	N/A
2012	+35.92%	N/A
2011	-34.12%	N/A

SXC vs DRUG Drawdown Comparison

The maximum drawdown for SXC was -90.43%, occurring on Jan 19, 2016. This drawdown has not yet recovered.

The maximum drawdown for DRUG was -97.68%, occurring on Jul 11, 2024. Recovery took 740 trading sessions.

The current SXC drawdown is -49.87%. The current DRUG drawdown is -22.27%.

Rank	SXC	DRUG
#1	-90.43% Aug 18, 2014 - Jan 19, 2016	-97.68% Nov 8, 2021 - Oct 18, 2024
#2	-44.70% Jul 25, 2011 - Oct 14, 2013	-58.28% Nov 6, 2024 - Sep 29, 2025
#3	-15.76% Apr 2, 2014 - Aug 6, 2014	-38.35% Jan 7, 2026 - Jun 15, 2026
#4	-9.64% Mar 6, 2014 - Mar 25, 2014	-27.84% Mar 22, 2021 - Aug 24, 2021
#5	-9.59% Dec 27, 2013 - Mar 6, 2014	-26.13% Oct 21, 2025 - Nov 28, 2025
#6	-6.84% Nov 29, 2013 - Dec 24, 2013	-19.30% Dec 16, 2025 - Jan 7, 2026
#7	-3.44% Mar 25, 2014 - Apr 2, 2014	-16.21% Sep 30, 2025 - Oct 9, 2025
#8	-1.86% Nov 5, 2013 - Nov 8, 2013	-14.42% Oct 11, 2021 - Nov 3, 2021
#9	-1.61% Nov 15, 2013 - Nov 21, 2013	-9.05% Oct 24, 2024 - Nov 4, 2024
#10	-0.29% Aug 12, 2014 - Aug 18, 2014	-7.65% Oct 14, 2025 - Oct 21, 2025
#11	N/A	-5.42% Dec 11, 2025 - Dec 16, 2025
#12	N/A	-4.62% Sep 24, 2021 - Sep 29, 2021
#13	N/A	-4.59% Dec 8, 2025 - Dec 10, 2025
#14	N/A	-4.38% Aug 24, 2021 - Sep 1, 2021
#15	N/A	-3.81% Sep 1, 2021 - Sep 17, 2021